These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 374734)

  • 21. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
    Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
    Szücs G; Szekanecz Z; Zilahi E; Kapitány A; Baráth S; Szamosi S; Végvári A; Szabó Z; Szántó S; Czirják L; György Kiss C
    Rheumatology (Oxford); 2007 Jun; 46(6):989-93. PubMed ID: 17384178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibody to gp50, a glycoprotein shared in common between fibroblasts and lymphocytes, in progressive systemic sclerosis.
    Alderuccio F; Witherden D; Toh BH; Barnett A
    Clin Exp Immunol; 1989 Oct; 78(1):26-30. PubMed ID: 2805420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal T cells in the blood of patients with systemic sclerosis.
    Marie I; Cordel N; Lenormand B; Hellot MF; Levesque H; Courtois H; Joly P
    Arch Dermatol; 2005 Jan; 141(1):88-9. PubMed ID: 15655151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients.
    Giacomelli R; Matucci-Cerinic M; Cipriani P; Ghersetich I; Lattanzio R; Pavan A; Pignone A; Cagnoni ML; Lotti T; Tonietti G
    Arthritis Rheum; 1998 Feb; 41(2):327-34. PubMed ID: 9485091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.
    Scala E; Paganelli R; Sampogna F; Abeni D; Colonna L; De Pità O; Puddu P; Russo G
    Clin Exp Immunol; 2005 Mar; 139(3):551-7. PubMed ID: 15730402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage infiltration in the skin of patients with systemic sclerosis.
    Ishikawa O; Ishikawa H
    J Rheumatol; 1992 Aug; 19(8):1202-6. PubMed ID: 1404154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity in progressive systemic sclerosis: no evidence for increased cytotoxicity against fibroblasts of different origin.
    Cooper SM; Friou GJ
    J Rheumatol; 1979; 6(1):25-9. PubMed ID: 439107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma.
    Alcocer-Varela J; Martinez-Cordero E; Alarcon-Segovia D
    Clin Exp Immunol; 1985 Mar; 59(3):666-72. PubMed ID: 3872755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced T lymphoid colony growth in patients with progressive systemic sclerosis and rheumatoid arthritis.
    Winkelstein A; Bernstein ML; Stevens MA; Rodnan GP; Medsger TA; Dobson SA
    J Lab Clin Med; 1982 Aug; 100(2):240-7. PubMed ID: 6980249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I.
    Hu PQ; Oppenheim JJ; Medsger TA; Wright TM
    J Autoimmun; 2006 Jun; 26(4):258-67. PubMed ID: 16735104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred.
    Soppi E; Lehtonen A; Toivanen A
    Clin Exp Immunol; 1982 Nov; 50(2):275-82. PubMed ID: 6217932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early T cell activation in the skin from patients with systemic sclerosis.
    Kalogerou A; Gelou E; Mountantonakis S; Settas L; Zafiriou E; Sakkas L
    Ann Rheum Dis; 2005 Aug; 64(8):1233-5. PubMed ID: 16014686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating T and B lymphocytes in progressive systemic sclerosis.
    de Jesus DG; Clancy RL
    J Rheumatol; 1975 Sep; 2(3):336-9. PubMed ID: 1081143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.
    Giordano M; Valentini G; Migliaresi S; Picillo U; Vatti M
    J Rheumatol; 1986 Oct; 13(5):911-6. PubMed ID: 3546686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early proliferative response in the human autologous mixed lymphocyte reaction in scleroderma.
    Alcocer-Varela J; Laffón A; Alarcón-Segovia D; Ibañez de Kasep G
    J Rheumatol; 1984 Feb; 11(1):48-52. PubMed ID: 6230451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.
    Baron M; Keystone EC; Gladman DD; Lee P; Poplonski L
    Clin Exp Immunol; 1981 Oct; 46(1):70-6. PubMed ID: 6978216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
    Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
    Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
    Doran M; Wordsworth P; Bresnihan B; Fitzgerald O
    J Rheumatol; 2001 Apr; 28(4):921-2. PubMed ID: 11327280
    [No Abstract]   [Full Text] [Related]  

  • 40. [T-lymphocyte values in peripheral blood in systemic lupus erythematosus and similar nosological entities (progressive systemic sclerosis, rheumatoid arthritis, and mixed connective tissue disease) (author's transl)].
    Rovenský J; Jarosková L; Zitnan D; Pekábek J; Svejcar J
    Cas Lek Cesk; 1982 Mar; 121(12):370-4. PubMed ID: 6979391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.